North America Plasma Fractionation Market by Key Players, Regional Segmentation and Forecasts, 2022 - 2028

Market Introduction

The North America plasma fractionation market is divided into the US, Canada, and Mexico. The growth of market is widely attributed by the growing application of coagulation factors concentrates, clotting factor concentrates and other plasma derived products to treat various hematological disorders such as hemophilia A, hemophilia B. Moreover, the growth of market in Canada is expected to grow due to increasing prevalence of multiple sclerosis and other neurological disorders. In addition, in Mexico, the market is estimated to grow owing to increasing awareness about blood and related disorders, immunological disorders along with rising awareness about plasma derived therapies in the treatment of chronic disorders.

North America Plasma Fractionation Market The COVID-19 pandemic is creating unprecedented operational and clinical challenges for healthcare institutions in the region. Moreover, the shift of priorities from chronic diseases and disorders treatments to COVID-19 diagnosis and treatment devices is leading to a decline in market growth up to a certain extent. North America Plasma Fractionation Market Although no specific drug therapy for COVID-19 has been approved, convalescent plasma therapy is expected to improve the survival rate of COVID-19 patients based on the results of a number of clinical trials. For instance, in North America, the food and drug administration has approved the emergency use authorization of convalescent plasma for the treatment and care of COVID-19 patients. The EUA, i.e., emergency use authorization, has authorized the distribution of convalescent plasma in the US for treating suspected and confirmed COVID-19 patients. Thus, the emergency use of convalescent plasma for treating COVID-19 patients is leading to a positive impact on market growth.

📚 Download Sample PDF Copy@ https://www.businessmarketinsights.com/sample/TIPRE00026277

Market Overview and Dynamics

The plasma fractionation market in North America is expected to grow from US$ 9,484.91 million in 2021 to US$ 14,740.90 million by 2028; it is estimated to grow at a CAGR of 6.5% from 2021 to 2028. The market players associated with metabolomics are actively exploring the possible innovative technologies to facilitate researchers and medical care as the plasma containing the essential components to treat a disease, such as antibodies. North America Plasma Fractionation Market Various studies are being carried out on the possible applications of plasma for illnesses that are difficult to cure by employing traditional approaches. Moreover, rising awareness about the advantages of blood donation and applications of plasma among people is expected to open new scope for the market.

Key Market Segments

North America plasma fractionation market is segmented into product, application, end user, and country. The North America plasma fractionation market, based on product, has been segmented into immunoglobulin, albumin, coagulation factor concentrates, protease inhibitors, and others. The immunoglobulin segment is likely to hold the largest share of the market in 2021. The North America plasma fractionation market, based on application is segmented into neurology, immunology, hematology, critical care, pulmonology, and others. In 2021, the Neurology segment is likely to hold the largest share of the market. The North America plasma fractionation market, based on end user is segmented into hospitals and clinics, clinical research laboratories, academic institutes. In 2021, the hospitals and clinics segment is likely to hold the largest share of the market. Based on country, the North America plasma fractionation market is segmented into the US, Canada, and Mexico. The US held the largest market share in 2020.

📚Full Report Link @ https://www.businessmarketinsights.com/reports/north-america-plasma-fractionation-market

The List of Companies

Bharat Serums and Vaccines Limited (BSV)

Bio Products Laboratory Ltd.

CSL Limited

Grifols, S.A.

Kedrion S.p.A

Octapharma AG

SK Plasma

Key Drivers of Market Growth

1.Rising Demand for Plasma-Derived Therapies: North America Plasma Fractionation Market Plasma-derived therapies are essential for treating a variety of chronic and acute conditions. For example, immunoglobulins are used to treat autoimmune disorders, while clotting factors are essential for individuals with hemophilia. With an increasing number of people being diagnosed with these conditions, the demand for plasma-derived therapies has risen, directly contributing to market growth.

2.Technological Advancements: The plasma fractionation process has evolved significantly in recent years. Advances in technologies such as affinity chromatography, viral inactivation methods, and continuous processing systems have improved the yield and quality of plasma-derived products. These innovations have made plasma fractionation more efficient, allowing producers to meet growing demand while maintaining safety and quality standards.

3.Aging Population: North America Plasma Fractionation Market The aging population in North America is another key factor driving the market. As people age, the incidence of conditions that require plasma-derived therapies, such as immune deficiencies, clotting disorders, and trauma, increases. This demographic shift has resulted in a higher demand for plasma products, further driving market growth.

4.Increased Plasma Donations: Both the United States and Canada have established systems that encourage plasma donation, which is vital for the fractionation process. The increase in plasma donations has ensured a steady supply of raw material, allowing the industry to meet the rising demand for plasma-derived products.

5.Awareness and Education: North America Plasma Fractionation Market Public awareness campaigns and educational efforts have played a critical role in increasing the number of plasma donations. Organizations such as the American Red Cross and Canadian Blood Services have been instrumental in educating the public about the importance of plasma donation, ensuring that the fractionation market continues to receive a steady supply of plasma.

Market Segmentation

The North American plasma fractionation market can be segmented based on product type, application, and end user.

Product Type:
Immunoglobulins: Immunoglobulins are used to treat conditions like primary and secondary immunodeficiencies and autoimmune diseases. This product segment holds the largest share of the market.
Clotting Factors: Clotting factors, such as Factor VIII and Factor IX, are crucial for treating hemophilia and other bleeding disorders. This segment is also a significant contributor to market growth.

Albumin: Albumin is commonly used in treating liver diseases, burns, and trauma. It is a key plasma product with consistent demand.
Other Plasma Proteins: This includes proteins such as alpha-1 antitrypsin, which is used in treating chronic obstructive pulmonary disease (COPD), and other specialized products for rare diseases.
Application:
Immunology: Plasma-derived immunoglobulins are primarily used in immunology to treat conditions like autoimmune diseases and immunodeficiencies.

Hematology: Hematology treatments, such as clotting factors, are used to treat bleeding disorders like hemophilia.
Neurology: Certain plasma-derived products are also used to treat neurological conditions, including multiple sclerosis.
Critical Care: Albumin and other plasma-derived proteins are used in critical care settings, including in the treatment of shock, burns, and liver failure.
End Users:
Hospitals and Clinics: Hospitals and clinics are the largest end users of plasma-derived products, as these therapies are often used in emergency settings or to manage chronic conditions.
Specialty Centers: Specialty treatment centers focused on rare diseases, hemophilia centers, and immunology centers also form a large part of the market.

Research Institutes: Research institutions focused on blood disorders, immunology, and hematology are key consumers of plasma-derived products for research and clinical trials.
Regional Analysis

United States: The United States holds the largest share of the North American plasma fractionation market, primarily due to its advanced healthcare infrastructure, high healthcare expenditure, and a large number of plasma donation centers. The country has a well-established network for both plasma collection and fractionation, with major companies like Grifols, CSL Behring, and Takeda operating in the market. Additionally, the U.S. government's support for the regulation and oversight of plasma collection and fractionation ensures that the industry maintains high standards of safety and quality.

Canada: While smaller than the U.S. market, Canada plays an important role in the North American plasma fractionation industry. Canada has a robust healthcare system, and organizations such as Canadian Blood Services oversee the collection of blood and plasma. Canada has seen a steady increase in plasma donations, which has supported the growth of the plasma fractionation industry. Moreover, Canadian companies are increasingly investing in R&D to develop new plasma-derived products and improve fractionation technologies.

You can see this-
Europe Industrial Gloves Market- https://postyourarticle.com/europe-industrial-gloves-market-global-analysis-size-share-growth-trends-and-forecast-2022-2028/
Europe Augmented Reality and Virtual Reality Market- https://www.globalpostnews.com/uncategorized/europe-augmented-reality-and-virtual-reality-market-by-key-players-and-forecasts-2022-2028/
Europe Sodium Benzoate Market- https://www.openpr.com/news/3911408/europe-sodium-benzoate-market-key-players-growth-trends
Europe EV Charging Infrastructure Market- https://fortunetelleroracle.com/g-blog/europe-ev-charging-infrastructure-market-global-analysis--size--share--growth--trends-and-forecast-2022---2028-1027758

Contact US
Contact Person : Ankit Mathur
Phone : +1-646-491-9876

About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

This release was published on openPR.